Longitudinal study of bone loss after thyroidectomy and suppressive thyroxine therapy in premenopausal women

Acta Endocrinol (Copenh). 1992 Mar;126(3):238-42. doi: 10.1530/acta.0.1260238.

Abstract

The effects of suppressive doses of L-thyroxine on the appendicular and axial bone mineral content were followed for 12-36 months after total or subtotal thyroidectomy in 15 premenopausal women. Compared to age-matched controls, these patients had a more marked bone loss of the spinal bone mineral content (2.6 +/- 1.9% vs 0.2 +/- 1.2% per year). The changes in radial cortical bone density were not significantly different from the control group. We conclude that when a suppressive therapy with L-thyroxine is necessary the rate of bone loss should be monitored at regular intervals.

MeSH terms

  • Adult
  • Bone Density
  • Bone Resorption*
  • Calcitonin / blood
  • Female
  • Humans
  • Longitudinal Studies
  • Menopause*
  • Middle Aged
  • Postoperative Period
  • Thyroidectomy*
  • Thyroxine / therapeutic use*

Substances

  • Calcitonin
  • Thyroxine